Eaton-Cambridge’s Johnson & Johnson JNJ Stock Holding History

Eaton-Cambridge’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Sell	1,058 -19	-2%	-$4.43K	0.08%	56
2026 Q1	$263K	Buy	+1,077	New	+$251K	0.08%	47

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Eaton-Cambridge's JNJ Position: Q2 2026 in Review

Eaton-Cambridge reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, selling an estimated $4.43K and leaving 1,058 shares worth $269K. The position accounts for 0.08% of the portfolio, ranked #56.

Eaton-Cambridge first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Eaton-Cambridge held 1,058 shares of Johnson & Johnson worth $269K as of Q2 2026.
Eaton-Cambridge sold 19 Johnson & Johnson shares in Q2 2026, an estimated $4.43K.
Johnson & Johnson made up 0.08% of Eaton-Cambridge's portfolio in Q2 2026, its #56 holding.
Eaton-Cambridge first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Eaton-Cambridge's 13F filing for Q2 2026, filed 23 Jul 2026.